MAGEA6, a member of the CTA family, is typically expressed only in the testes and placenta, where it plays essential roles in spermatogenesis and embryonic development.[46] However, its expression in tumors has been increasingly recognized as a potential cancer biomarker. Here, MAGEA6 is linked to cancer.